Effect of Intensive LDL-cholesterol Targeting for Elderly Patients With Cardiovascular Disease: I-OLD Trial - Trial NCT05361421
Access comprehensive clinical trial information for NCT05361421 through Pure Global AI's free database. This Phase 4 trial is sponsored by Yonsei University and is currently Recruiting. The study focuses on Cardiovascular Disease. Target enrollment is 1200 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Yonsei University
Timeline & Enrollment
Phase 4
Sep 14, 2022
Oct 01, 2027
Primary Outcome
Clinical efficacy of intensive lipid-lowering therapy
Summary
Although there have been studies regarding intensive lowering of low-density lipoprotein
 (LDL)-cholesterol with high intensity statins in patients with cardiovascular disease,
 elderly patients were either excluded or accounted only a small portion of study subjects.
 Therefore, this study sought to compare the clinical outcomes according to the
 LDL-cholesterol therapy targeting (intensive targeting [LDL-cholesterol 55mg/dL] vs.
 conventional therapy [moderate intensity statin therapy]) in elderly patients with ≥75 years
 and documented cardiovascular disease.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05361421
Non-Device Trial